Covid Resources
About Crohn’s & Colitis
COVID-19 and IBD
Crohn’s and Colitis Canada COVID-19 and IBD task force guidance statements
(Updated March 14, 2023)
Note from the COVID-19 and IBD Task Force:
The Crohn’s and Colitis Canada COVID-19 and IBD Task Force was formed in March 2020 when the SARS-CoV-2 (COVID-19) pandemic was declared. The purpose of the Task Force was to:
- Assess the impact of COVID-19 on people living with inflammatory bowel disease (IBD),
- Interpret the rapidly evolving evidence of risk, vaccination and treatment of COVID-19 in people with IBD, and
- Provide the IBD community with educational resources and guidance.
Long Covid Game
//Hello, Worlds
The Long COVID Game
Research | Design | Play
Exploring how we understand ourselves, each other, and the worlds around us through games and play.
Sick with COVID? What To Do
This is a facilitator’s guide for The Long COVID Game, an instructional game on the increasing risks of contracting Long COVID with repeated infections.
Overview
This short (<5min) instructional game can help illustrate the risks of repeated COVID infections and the chance of acquiring Long COVID. It was designed for large groups, such as a classroom of students. The goal is to communicate the benefits of wearing a respirator, such as an N95, to reduce the number of COVID infections and thus the risk of contracting Long COVID.
Sick with COVID
Sick with COVID? What To Do
You’re not alone. Most people recover from their initial infection. These recommendations will give you the best chance to recover and prevent others from being infected.
Request Covid Accommodation
Digital Download: Request for Covid Accommodation in Health Care Facilities
Everyone deserves safe access to health care, but we know many people are facing resistance to simple, reasonable requests for Covid accommodations like respirators and air filters cleaners.
So we’re making it easier for you to request accommodations from your primary care doctor, dentist, specialists, or other health care workers, with a fillable PDF form that clearly lays out your requested accommodations and your legal rights to them.
Download our Request for Accommodation in Health Care Facilities PDF today.
COVID Patients Exhale High Numbers of Virus
COVID Patients Exhale High Levels of Virus the First Eight Days
COVID patients exhale high numbers of virus during the first eight days after symptoms start, as high as 1,000 copies per minute, reports a new Northwestern Medicine study. It is the first longitudinal, direct measure of the number of SARS-CoV-2 viral copies exhaled per minute over the course of the infection — from the first sign of symptoms until 20 days after. On day eight, exhaled levels of virus drop steeply, down to near the limit of detection —an average of two copies exhaled per minute
Covid 19 and Bone Health
COVID-19 and Bone Health
Current evidence and reports indicate a direct relationship between SARS-CoV-2 infection and bone health, with SARS-CoV-2 having a significant negative effect on bone health. In this review, we analyzed the impact of SARS-CoV-2 infection on bone health and assessed the impact of COVID-19 on the diagnosis and treatment of osteoporosis.
How to Stop Covid from Spreading
We had COVID come into our home. How we stopped it from spreading
Author: Joey Fox, P. Eng, M.A.Sc @joeyfox85
We stopped COVID in our home! My wife felt sick early last week and then tested positive (RAT). Everyone in our family is now negative. My kids and I never got it. We didn’t resort to extreme measures like isolation or kids wearing N95s all day. This is how we did it.
Covid-19 Spread By Aerosols
COVID-19 is spread by aerosols (airborne): an evidence review
There are still many who argue strongly against the role of aerosols in the transmission of COVID-19. In general, I think these arguments clash with science and have significant logical inconsistencies. Before getting to the evidence that COVID-19 is spread by aerosols, let’s dispel a few widely held misconceptions.
#CovidIsAirborne
From the World Health Network
COVID-19 is airborne, and COVID particles can hang in the air for hours. It is still possible to stay safe at indoor gatherings.
For more information on proper ventilation, see our ventilation guidelines. For information on staying safe in everyday life, see our guidelines for individuals.
Welcome to Covid Safe Network
By clicking “Read More” below you will find links to businesses and schools that take Covid precautions to protect their customers and staff. You will also find links to studies and news stories that demonstrate the severity of Covid-19.
COVID SAFETY 101 (2023)
Covid (SARS-Cov-2) is short for severe acute respiratory syndrome
coronavirus 2. The virus is airborne and neuroinvasive. It causes vascular
disease and dysregulates immune systems.
The pandemic is not over, the virus never became milder, and the government has continually lied about the threat.
Covid Lists
A curated list of 337 bookmarks (and growing) about all things COVID-19. This is a great first stop if you are looking for information ranging from Research to consumer products.
List of 2250 COVID-19 Studies
This extensive list of research studies and articles was curated by Zotero. Zotero is a free, easy-to-use tool to help you collect, organize, annotate, cite, and share research. Information dates back to December 2019 before the world knew we were heading into a pandemic.
COVID-19 epidemiology update: Current situation
Summary of COVID-19 cases, hospitalizations and deaths, cases following vaccination, testing and variants of concern across Canada and over time. Older versions of this report are available on the archived reports page.
Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19
We compared 1656 exposed and 1656 unexposed children from 1 February 2020 to 30 November 2021. The overall excess risk for new-onset conditions after COVID-19 was 78% higher in the exposed than unexposed children. We found significantly higher risks for some new conditions in exposed children, including mental health issues (aHR 1.8, 95% CI 1.1–3.0) and neurological problems (aHR 2.4, 95% CI 1.4–4.1).
Conclusion
Exposed children had a 78% higher risk of developing new conditions of interest after COVID-19 than unexposed children.
By Ruth Ann Crystal MD
Updated Weekly
Dr. Ruth’s SubStack publishes updates on COVID news and more weekly. If you subscribe for free, you can receive her weekly updates by E-mail. Information is about COVID-19 in the US.
Use of Electronic Clinical Data to Track Incidence and Mortality for SARS-CoV-2–Associated Sepsis
FREE COVID Safety Resource List
Your ultimate guide to staying covid-safe
@violetblue.bsky.social has compiled a very extensive and informative list of questions, answers and links about COVID. She constantly updates this list making it a good bookmark to return to. Thank you Violet.
Share it with anyone who needs it.
No one is safe until all of us are safe.
Cheat sheet for doctors and nurses and to leave in waiting rooms
About COVID-19 Resources Canada
COVID-19 Resources Canada is an online national platform where we can join efforts to respond to the COVID-19 pandemic in Canada.
We collect videos, infographics and written explainers developed for non-scientists, plus resources with more scientific detail. Feel free to learn from them yourself, or to share them with those around you.
Follow this direct link to the Canadian Hazard COVID-19 Index which is regularly updated with data for Canada and for individual provinces.
Other Site Links
Intranasal Trivalent MMS Vaccine
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern
There is an urgent need to develop a mucosal SARS-CoV-2 vaccine that can induce broad, durable protection. MMR has been one of the safest and most successful vaccines in human history. By expressing the six-proline-stabilized prefusion spikes from three diverse SARS-CoV-2 strains in the MeV, MuV-JL1, and MuV-JL2 vaccine strains from MMR, we generated a MMS trivalent vaccine candidate. Intranasally delivered MMS induced strong SARS-CoV-2-specific neutralizing antibody, mucosal IgA, and systemic and lung resident T cell immune responses that provide broad protection against challenge with each of these three strains. Therefore, MMS is a highly promising next-generation vaccine candidate against COVID-19. Furthermore, any of the three component vaccine viruses can be quickly modified when a new important SARS-CoV-2 variant appears.